Article

Development of a Micro-Computed Tomography–Based Image-Guided Conformal Radiotherapy System for Small Animals

Department of Radiation Oncology, Stanford University, Stanford, CA 94305-5847, USA.
International journal of radiation oncology, biology, physics (Impact Factor: 4.18). 09/2010; 78(1):297-305. DOI: 10.1016/j.ijrobp.2009.11.008
Source: PubMed

ABSTRACT To report on the physical aspects of a system in which radiotherapy functionality was added to a micro-computed tomography (microCT) scanner, to evaluate the accuracy of this instrument, and to and demonstrate the application of this technology for irradiating tumors growing within the lungs of mice.
A GE eXplore RS120 microCT scanner was modified by the addition of a two-dimensional subject translation stage and a variable aperture collimator. Quality assurance protocols for these devices, including measurement of translation stage positioning accuracy, collimator aperture accuracy, and collimator alignment with the X-ray beam, were devised. Use of this system for image-guided radiotherapy was assessed by irradiation of a solid water phantom as well as of two mice bearing spontaneous MYC-induced lung tumors. Radiation damage was assessed ex vivo by immunohistochemical detection of gammaH2AX foci.
The positioning error of the translation stage was found to be <0.05 mm, whereas after alignment of the collimator with the X-ray axis through adjustment of its displacement and rotation, the collimator aperture error was <0.1 mm measured at isocenter. Computed tomography image-guided treatment of a solid water phantom demonstrated target localization accuracy to within 0.1 mm. Gamma-H2AX foci were detected within irradiated lung tumors in mice, with contralateral lung tissue displaying background staining.
Addition of radiotherapy functionality to a microCT scanner is an effective means of introducing image-guided radiation treatments into the preclinical setting. This approach has been shown to facilitate small-animal conformal radiotherapy while leveraging existing technology.

Download full-text

Full-text

Available from: Phuoc T Tran, Aug 25, 2015
0 Followers
 · 
150 Views
  • Source
    • "Discussion RT is a standard treatment for GBM as well as other brain and head and neck cancers. Until the development of commercially available small animal image-guided microirradiators like the SARRP, preclinical research in these disease sites was limited by small animal radiation techniques that lagged decades behind current clinical practice in the precise targeting of tumor volumes and the sparing of normal tissue [2] [3]. Previously, only superficial tumors could be targeted with any degree of precision using crude lead blocking to shield the surrounding normal tissue. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Preclinical studies of cranial radiation therapy (RT) using animal brain tumor models have been hampered by technical limitations in the delivery of clinically relevant RT. We established a bioimageable mouse model of glioblastoma multiforme (GBM) and an image-guided radiation delivery system that facilitated precise tumor localization and treatment and which closely resembled clinical RT. Our novel radiation system makes use of magnetic resonance imaging (MRI) and bioluminescent imaging (BLI) to define tumor volumes, computed tomographic (CT) imaging for accurate treatment planning, a novel mouse immobilization system, and precise treatments delivered with the Small Animal Radiation Research Platform. We demonstrated that, in vivo, BLI correlated well with MRI for defining tumor volumes. Our novel restraint system enhanced setup reproducibility and precision, was atraumatic, and minimized artifacts on CT imaging used for treatment planning. We confirmed precise radiation delivery through immunofluorescent analysis of the phosphorylation of histone H2AX in irradiated brains and brain tumors. Assays with an intravenous near-infrared fluorescent probe confirmed that radiation of orthografts increased disruption of the tumor blood-brain barrier (BBB). This integrated model system, which facilitated delivery of precise, reproducible, stereotactic cranial RT in mice and confirmed RT's resultant histologic and BBB changes, may aid future brain tumor research.
    Translational oncology 08/2012; 5(4):230-7. DOI:10.1593/tlo.12136 · 3.40 Impact Factor
  • Source
    • "Recognizing the pressing need to bridge this translational gap for radiation research, several groups have initiated development of small animal irradiators [5] [6]. Our group has developed a small animal radiation research platform (SARRP) incorporating: 1) a gantry and robotic stage that supports isocentric and noncoplanar conformal irradiation and 2) on-board cone-beam CT (CBCT) guidance to facilitate coregistration with other imaging and accurate repositioning for fractionated therapy [7]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We report on a novel preclinical pancreatic cancer research model that uses bioluminescence imaging (BLI)-guided irradiation of orthotopic xenograft tumors, sparing of surrounding normal tissues, and quantitative, noninvasive longitudinal assessment of treatment response. Luciferase-expressing MiaPaCa-2 pancreatic carcinoma cells were orthotopically injected in nude mice. BLI was compared to pathologic tumor volume, and photon emission was assessed over time. BLI was correlated to positron emission tomography (PET)/computed tomography (CT) to estimate tumor dimensions. BLI and cone-beam CT (CBCT) were used to compare tumor centroid location and estimate setup error. BLI and CBCT fusion was performed to guide irradiation of tumors using the small animal radiation research platform (SARRP). DNA damage was assessed by γ-H2Ax staining. BLI was used to longitudinally monitor treatment response. Bioluminescence predicted tumor volume (R = 0.8984) and increased linearly as a function of time up to a 10-fold increase in tumor burden. BLI correlated with PET/CT and necropsy specimen in size (P < .05). Two-dimensional BLI centroid accuracy was 3.5 mm relative to CBCT. BLI-guided irradiated pancreatic tumors stained positively for γ-H2Ax, whereas surrounding normal tissues were spared. Longitudinal assessment of irradiated tumors with BLI revealed significant tumor growth delay of 20 days relative to controls. We have successfully applied the SARRP to a bioluminescent, orthotopic preclinical pancreas cancer model to noninvasively: 1) allow the identification of tumor burden before therapy, 2) facilitate image-guided focal radiation therapy, and 3) allow normalization of tumor burden and longitudinal assessment of treatment response.
    Translational oncology 04/2012; 5(2):77-84. DOI:10.1593/tlo.11316 · 3.40 Impact Factor
  • Source
    • "While there have been various approaches in design and implementation, a common theme is to incorporate image guidance with conformal, small field radiotherapy to enable preclinical studies. Notable efforts in small animal irradiator development have been presented by research teams from Washington University School of Medicine (Stojadinovic et al 2006, 2007, Kiehl et al 2008), Johns Hopkins University (Deng et al 2007, Matinfar et al 2007, Matinfar et al 2009, Wong et al 2008), Stanford University (Bazalova et al 2009, Graves et al 2007, Motomura et al 2010, Zhou et al 2010), Princess Margaret Hospital (Lindsay et al 2008, Lindsay et al 2009, Chow and Leung 2007, Clarkson et al 2011), University of Arkansas Medical Sciences (Moros et al 2009, Sharma et al 2009) and University of Texas Southwestern (Cho et al 2010, Saha et al 2010, Song et al 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Small animal irradiation provides an important tool used by preclinical studies to assess and optimize new treatment strategies such as stereotactic ablative radiotherapy. Characterization of radiation beams that are clinically and geometrically scaled for the small animal model is uniquely challenging for orthovoltage energies and minute field sizes. The irradiator employs a commercial x-ray device (XRAD 320, Precision x-ray, Inc.) with a custom collimation system to produce 1-10 mm diameter beams and a 50 mm reference beam. Absolute calibrations were performed using the AAPM TG-61 methodology. Beam's half-value layer (HVL) and timer error were measured with an ionization chamber. Percent depth dose (PDD), output factors (OFs) and off-axis ratios were measured using radiochromic film, a diode and a pinpoint ionization chamber at 19.76 and 24.76 cm source-to-surface distance (SSD). PDD measurements were also compared with Monte Carlo (MC) simulations. In-air and in-water absolute calibrations for the reference 50 mm diameter collimator at 19.76 cm SSD were measured as 20.96 and 20.79 Gy min(-1), respectively, agreeing within 0.8%. The HVL at 250 kVp and 15 mAs was measured to be 0.45 mm Cu. The reference field PDD MC simulation results agree with measured data within 3.5%. PDD data demonstrate typical increased penetration with increasing field size and SSD. For collimators larger than 5 mm in diameter, OFs measured using film, an ion chamber and a diode were within 3% agreement.
    Physics in Medicine and Biology 03/2011; 56(8):2585-99. DOI:10.1088/0031-9155/56/8/016 · 2.92 Impact Factor
Show more